top of page

Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome
Zimmermann, Anca; Zimmermann, Tim; Schattenberg, Jörn; Pöttgen, Sebastian; Lotz, Johannes; Rossmann, Heidi; Roeddiger, Ralf; Biesterfeld, Stefan; Geiss, Hans-Christian; Schuchmann, Marcus; Galle, Peter R.; Weber, Matthias M.
Abstract:
BACKGROUND: NASH (non-alcoholic steatohepatitis) is considered the hepatic manifestation of the metabolic syndrome (MS). We aimed to analyze lipid, carbohydrate, and iron metabolism in NASH. PATIENTS, METHODS: 37 patients with MS (17 M/20 F, 51+/-15 years), elevated transaminases; 25 patients had histologically proven NASH (NAS score≥5), 12 patients had toxic background (nonNASH). 37 age, sex, BMI-matched healthy controls. Lipid variables, LDL-subfractions, iron, ferritin, transferrin (T), transferrin saturation (TS), and hepcidin (H) were measured in patients/controls. Oral glucose tolerance tests were performed. RESULTS: NASH patients with steatosis gr. 2 and 3 (>33% hepatic fat) had higher sd-LDL (mg/dl) concentrations than patients with steatosis gr. 1 (33% (p=0.04). NASH-patients showed higher insulin, C-peptide and IRI values than nonNASH patients (p=0.034; 0.032; 0.04). H was increased in patients versus controls (p<0.001). H correlated with ferritin in MS-patients (p=0.01), correlated directly with sd-LDL (mg/dl) (p=0.017) and IRI (p
Automatic Tags
Female; Humans; Male; Adult; Aged; Middle Aged; C-Peptide; Insulin; Glucose Tolerance Test; Metabolic Syndrome; Carbohydrate Metabolism; Lipid Metabolism; Fatty Liver; Cholesterol, LDL; Non-alcoholic Fatty Liver Disease; Ferritins; Iron; Metabolome; Transferrin; Antimicrobial Cationic Peptides; Hepcidins
bottom of page

